InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
Subscribe Login/Register
S&P 500
5,277.51
(
0.80%
)
US TECH 100
18,064.80
(
0.02%
)
Dow Jones
38,686.32
(
1.51%
)
Brent Oil
81.30
(
0.00%
)
Bitcoin
67,609.87
(
0.19%
)
Post# of 30990
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Replies (2) Keep Next 10 Report Keyboard Shortcuts
Replies (2) Next 10 Prev Next

knuts4oe

Send PM Follow Ignore
Followers 4
Posts 682
Boards Moderated 0
Alias Born 06/26/2013

knuts4oe

Re: tensurf post# 28413

Friday, 07/28/2017 9:15:45 PM

Friday, July 28, 2017 9:15:45 PM

Post# of 30990
tensurf

Should Nilvad turn out to be the first medication that interrupts the progression of Alzheimer's to any degree, there would be an instant pent up demand for it. Archer could easily license it to one or more pharmas for hundreds of millions, IN MY OPINION! That funding could easily permit a spinning off of Archer and merger with a reincorporated Rock Creek. Would former Rock Creek shareholders be retained? My guess is "yes", because we are shareholders along with Jonnie Williams. But only time will tell us if this is just a pipe dream!
Public Reply Private Reply New Post
Keep Last Read
Replies (2) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (2) Next 10 Prev Next

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Sign Up